Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Naylor

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinonesM Jaffar, S A Everett, M A Naylor, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assayV K Langmuir, K R Laderoute, H L Mendonca, et al.
Journal of Medicinal Chemistry|September 1, 1990
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxinsT C Jenkins, M A Naylor, P O'Neill, et al.
Journal of Medicinal Chemistry|July 21, 1998
Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitroM A Naylor, E Swann, S A Everett, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Bioorganic & Medicinal Chemistry Letters|February 17, 1999
Prodrugs for targeting hypoxic tissues: regiospecific elimination of aspirin from reduced indolequinonesM Jaffar, S A Everett, M A Naylor, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1996
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assayV K Langmuir, K R Laderoute, H L Mendonca, et al.
Journal of Medicinal Chemistry|September 1, 1990
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxinsT C Jenkins, M A Naylor, P O'Neill, et al.
Journal of Medicinal Chemistry|July 21, 1998
Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitroM A Naylor, E Swann, S A Everett, et al.
Pageof 4